Advertisement
BRKR vs ICCM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a Hold and ICCM is a Hold.
BRKR sees its Stochastic Oscillator recovers from oversold territory
On October 21, 2026, the Stochastic Oscillator for BRKR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 67 instances where the indicator left the oversold zone. In 47 of the 67 cases the stock moved higher in the following days. This puts the odds of a move higher at over 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +6.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRKR advanced for three days, in 200 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
BRKR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRKR as a result. In 71 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for BRKR turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 34 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
BRKR moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BRKR crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRKR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.667) is normal, around the industry mean (2.874). P/E Ratio (-81.871) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (11.052). Dividend Yield (0.003) settles around the average of (0.009) among similar stocks. P/S Ratio (2.634) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. BRKR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRKR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ICCM's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ICCM turned positive on October 19, 2026. Looking at past instances where ICCM's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 66 cases where ICCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICCM advanced for three days, in 161 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for ICCM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.390) is normal, around the industry mean (2.874). P/E Ratio (-0.147) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.297) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. ICCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
BRKR | ICCM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 100 | |
PRICE GROWTH RATING 1..100 | 40 | 96 | |
P/E GROWTH RATING 1..100 | 99 | 7 | |
SEASONALITY SCORE 1..100 | 85 | 17 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BRKR's Valuation (9) in the Medical Specialties industry is somewhat better than the same rating for ICCM (47) in the null industry. This means that BRKR’s stock grew somewhat faster than ICCM’s over the last 12 months.
BRKR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICCM (100) in the null industry. This means that BRKR’s stock grew similarly to ICCM’s over the last 12 months.
BRKR's SMR Rating (92) in the Medical Specialties industry is in the same range as ICCM (100) in the null industry. This means that BRKR’s stock grew similarly to ICCM’s over the last 12 months.
BRKR's Price Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for ICCM (96) in the null industry. This means that BRKR’s stock grew somewhat faster than ICCM’s over the last 12 months.
ICCM's P/E Growth Rating (7) in the null industry is significantly better than the same rating for BRKR (99) in the Medical Specialties industry. This means that ICCM’s stock grew significantly faster than BRKR’s over the last 12 months.
| BRKR | ICCM | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 74% |
| Momentum ODDS (%) | 1 day ago 76% | N/A |
| MACD ODDS (%) | 1 day ago 79% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| Advances ODDS (%) | 2 days ago 69% | 4 days ago 77% |
| Declines ODDS (%) | 9 days ago 74% | 11 days ago 88% |
| BollingerBands ODDS (%) | 1 day ago 64% | 1 day ago 76% |
| Aroon ODDS (%) | N/A | 1 day ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRKR’s FA Score shows that 1 FA rating(s) are green while ICCM’s FA Score has 1 green FA rating(s).
- BRKR’s FA Score: 1 green, 4 red.
- ICCM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRKR’s TA Score shows that 4 TA indicator(s) are bullish while ICCM’s TA Score has 4 bullish TA indicator(s).
- BRKR’s TA Score: 4 bullish, 4 bearish.
- ICCM’s TA Score: 4 bullish, 2 bearish.
Price Growth
BRKR (@Medical/Nursing Services) experienced а +6.30% price change this week, while ICCM (@Medical/Nursing Services) price change was +3.85% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
BRKR is expected to report earnings on Nov 02, 2026.
ICCM is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BRKR and
Correlation & Price change
A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.
| Ticker / NAME | Correlation To BRKR | 1D Price Change % | ||
|---|---|---|---|---|
| BRKR | 100% | -3.04% | ||
| A - BRKR | 78% Closely correlated | -2.17% | ||
| MTD - BRKR | 75% Closely correlated | +0.40% | ||
| WAT - BRKR | 68% Closely correlated | -0.41% | ||
| RVTY - BRKR | 68% Closely correlated | +0.48% | ||
| TMO - BRKR | 66% Loosely correlated | -2.52% | ||
More | ||||
ICCM and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.
| Ticker / NAME | Correlation To ICCM | 1D Price Change % | ||
|---|---|---|---|---|
| ICCM | 100% | -7.41% | ||
| SINT - ICCM | 67% Closely correlated | -4.07% | ||
| ILMN - ICCM | 31% Poorly correlated | -4.76% | ||
| PEN - ICCM | 31% Poorly correlated | +0.43% | ||
| BRKR - ICCM | 29% Poorly correlated | -3.04% | ||
| BNGO - ICCM | 29% Poorly correlated | -5.60% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MRGR | 45.60 | 0.09 | +0.19% |
| ProShares Merger ETF (MRGR) | |||
| FCTE | 29.54 | -0.20 | -0.68% |
| SMI 3Fourteen Full-Cycle Trend ETF (FCTE) | |||
| FDD | 19.05 | -0.17 | -0.88% |
| First Trust STOXX European Select Dividend Income Fund | |||
| DEMZ | 48.02 | -0.74 | -1.52% |
| Democratic Large Cap Core ETF (DEMZ) | |||
| EEM | 61.72 | -1.85 | -2.91% |
| iShares MSCI Emerging Markets ETF (EEM) | |||